NewsRoom Articles - Page 35 of 593

FridayAug 16, 2024 4:20 pm

420 with CNW — New Scientific Review Says Medical Cannabis Shows Promise in Treating Tourette Syndrome

A recent scientific review has delved into the possible therapeutic benefits of marijuana-based medicine for treating Tourette syndrome (TS), revealing that medical cannabis might significantly help reduce the intensity of premonitory urges and tics associated with the condition. The review’s authors examined nine studies with 401 TS patients. The findings suggest that while more research is necessary — particularly studies involving larger participant groups, standardized dosages and consistent drug formulations — marijuana-based medicine (MBM) holds promise as a treatment option for individuals with TS. “The current study demonstrates promising and perhaps advantageous results with MBM in terms of reducing the…

FridayAug 16, 2024 10:00 am

Research Shows Marijuana Could Lower Opioid Use

Patients with opioid-use disorder often must go above and beyond to access life-saving drugs such as methadone and suboxone as well as naloxone, the drug that reverses overdoses. In the last 10 years, opioid overdose mortality rates have increased significantly, mainly because of fentanyl in the illicit drug trade in America. Now, a new study has determined that marijuana may help reduce the use of opioids or even stop their use completely. The study was led by Sid Ganesh, a PhD student at the School of Medicine, University of Southern California (USC). For their study, the researchers interviewed 30 individuals…

FridayAug 16, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment

Lexaria, a global innovator in drug delivery platforms, is exploring its patented DehydraTECH(TM) technology for the oral delivery of glucagon-like peptide-1 (“GLP-1”) drugs. GLP-1 drugs have shown great promise in addressing diabetes and obesity, with nearly all the major brands administered only through injection devices. A previous human study by Lexaria evidenced improved bioavailability when semaglutide was administered orally, as compared to standard Rybelsus®. Lexaria has several additional R&D studies underway, including both animal and human investigations into semaglutide, liraglutide and tirzepatide. Together, those three drugs represent more than 90% of all revenue in the current global GLP1 market. Data…

ThursdayAug 15, 2024 4:20 pm

420 with CNW — Ohio Dispensaries See Long Lines as Recreational Marijuana Sales Begin

Last week, Ohioans flocked to dispensaries for the highly anticipated launch of recreational cannabis sales. Almost 100 medical cannabis dispensaries were permitted to sell recreational marijuana to adults after obtaining operational certificates from the state’s marijuana control division. In Cincinnati, Jeffrey Reide was so excited about the historic day that he camped out in his car to ensure he would be the first in line at a local dispensary. “I’m thrilled; this has been a long time coming,” Reide said, reflecting the sentiment of many others eagerly awaiting this moment. Similar scenes were observed in Youngstown and Columbus, where dispensaries…

WednesdayAug 14, 2024 4:20 pm

420 with CNW — Nebraska’s Judiciary Committee Considers Measures to Legalize, Regulate, Tax Adult-Use Marijuana

The Nebraska Judiciary Committee recently reviewed two proposals aimed at legalizing cannabis for adults aged 21 and older. Senator Justin Wayne introduced LB52, which outlines a regulatory structure for the marijuana industry, including a 25% sales and excise tax on marijuana products. The tax revenue would be allocated to the Education Future Fund. Additionally, LB52 proposes the creation of the Nebraska Marijuana Enforcement Commission to supervise the sector, administer licenses and impose sanctions for infractions. Another proposal, LB71, was put forward by Senator Terrell McKinney. This bill also seeks to legalize recreational marijuana but suggests a 16% sales and excise…

WednesdayAug 14, 2024 10:00 am

As Legalization Spreads, Trump Now Says Marijuana Criminalization Is Wrong

During a recent press conference, former President Donald Trump agreed that individuals should not be criminalized over cannabis, seeing as it was being legalized in different parts of the country. He added that he would soon reveal his position on the marijuana legalization bill on the November ballot in Florida, where he is a resident. A reporter had asked Trump about the current administration’s push to reschedule marijuana as well as statements made by Vice President Kamala Harris on how individuals need not be incarcerated over simple marijuana offenses. Trump responded, noting that it was hard to have individuals in…

TuesdayAug 13, 2024 4:20 pm

420 with CNW — Marijuana Companies Are Incorporating Reused Inputs in Packaging

While quantifying the exact amount of waste produced by the regulated cannabis sector is challenging, it’s evident that the waste generated is substantial. According to the National Cannabis Industry Association, cannabis byproducts in landfills contribute to an increase in carbon emissions of about 27,876 metric tons annually. Additionally, a 2020 study indicated that the U.S. marijuana industry produced approximately 1,754 tons of fresh and 520 tons of dry-weight trash that year. This figure does not even include packaging waste, which could potentially surpass the estimated biomass waste. Disposable vaporizers have become increasingly popular in the last few years due to…

MondayAug 12, 2024 4:20 pm

420 with CNW — Kamala Harris Backs Marijuana Legalization, a First for Major Presidential Candidate

Vice President Kamala Harris’s opinions on marijuana have changed over time, much like those of many other Americans. Back in 2010, she urged voters to reject a ballot measure that sought to legalize recreational marijuana when she was the district attorney for San Francisco. Her position at the time was in accord with that of a majority of California voters, of whom 54% eventually voted against the initiative. However, the perspective on marijuana began to change not long after. By 2016, California voters had passed Proposition 64, which legalized cannabis throughout the state. Then, in 2019, as California’s junior senator,…

MondayAug 12, 2024 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program

The company provided updates for its study programs for 2024, with a focus on its glucagon-like peptide-1 (“GLP-1”) agonist research program, targeting a significant step up in addressing worldwide diabetes and obesity, a tremendous market Lexaria has its Human Pilot Study #3 lined up, as well as its chronic dosing human study, both studies will begin dosing later this year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). Of note was growth in cash and marketable securities from $1.5 million during…

MondayAug 12, 2024 10:00 am

Australian Farmers Look to Tap Continental Opportunities as Cannabis Laws Ease

The marijuana business in Australia is booming, with farms in the country expanding to capitalize on growing demand. Estimates show that global legal marijuana spending may hit $153 billion by 2027. This is quite an increase, especially when compared to the $56 billion spent in 2022. While most of the growth has been driven by consumers of recreational marijuana in the United States, companies in Australia are focusing on the medical marijuana side of this market. Numbers of medical marijuana patients in Europe are expected to increase by more than 230% during the next four years. This may significantly bolster…